We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Appili Therapeutics, a biopharma company focused on anti-infective drug development, announced that it has signed a collaboration, development and supply agreement with Dr Reddy’s Laboratories and Global Response Aid (GRA).